CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022				96,768,745	53,137,729
Beginning balance at Dec. 31, 2022	$ 316,769			$ 10	$ 5	$ 559,106	$ (3,611)	$ (238,741)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)					77,941
Exercise of stock options	63					63
Vesting of restricted stock units (in shares)				381,592
Conversion of Class B shares into Class A common stock (in shares)				404,919	(404,919)
Stock-based compensation	5,912					5,912
Comprehensive loss	230						230
Net loss	(35,166)							(35,166)
Ending balance (in shares) at Mar. 31, 2023				97,555,256	52,810,751
Ending balance at Mar. 31, 2023	287,808			$ 10	$ 5	565,081	(3,381)	(273,907)
Beginning balance (in shares) at Dec. 31, 2023		102,579,222	52,547,761	102,579,222	52,547,761
Beginning balance at Dec. 31, 2023	$ 185,329			$ 10	$ 5	579,848	(3,335)	(391,199)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	25,000				25,000
Exercise of stock options	$ 52					52
Vesting of restricted stock units (in shares)				619,392
Conversion of Class B shares into Class A common stock (in shares)				25,000	(25,000)
Stock-based compensation	3,431					3,431
Comprehensive loss	(1,213)						(1,213)
Net loss	(27,331)							(27,331)
Ending balance (in shares) at Mar. 31, 2024		103,223,614	52,547,761	103,223,614	52,547,761
Ending balance at Mar. 31, 2024	$ 160,267			$ 10	$ 5	$ 583,330	$ (4,548)	$ (418,530)